Home » Stocks » NLSP

NLS Pharmaceutics Ltd. (NLSP)

Stock Price: $3.25 USD -0.03 (-0.92%)
Updated May 12, 2021 4:00 PM EDT - Market closed
Market Cap 38.28M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 11.78M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 12
Last Price $3.25
Previous Close $3.28
Change ($) -0.03
Change (%) -0.92%
Day's Open 3.37
Day's Range 3.18 - 3.38
Day's Volume 80,660
52-Week Range 2.06 - 7.35

News

There are no news available yet.

About NLSP

NLS Pharmaceutics is an innovative biotechnology company engaged in the discovery and development of life-improving drug therapies to treat rare and complex central nervous system, or CNS, disorders, including narcolepsy, idiopathic hypersomnia and other rare sleep disorders, and of neurodevelopmental disorders, such as Attention Deficit Hyperactivity Disorder, or ADHD. CNS disorders are a diverse group of conditions that include neurological, psychiatric, and substance use disorders. According to the World Health Organization and based on data... [Read more...]

Industry
Biotechnology
IPO Date
Jan 29, 2021
CEO
Alexander Zwyer
Employees
1
Stock Exchange
NASDAQ
Ticker Symbol
NLSP
Full Company Profile

Financial Performance

Financial Statements